FDA Warns of Implantable Infusion Pumps in MRI
The Food and Drug Administration (FDA) has received reports of serious adverse events, including death, associated with the use of implantable infusion pumps in the magnetic resonance environment.

The adverse event reports contained medication dosing errors such as over- or under-infusion, and unintended boluses, as well as mechanical pump problems (eg, motor stall, pump not restarting) after magnetic resonance imaging [MRI] exam...

http://www.neurologyadvisor.com/general-neurology/fda-warning-use-of-implantable-infusion-pumps-in-mri/article/632527/
Like
Comment
Share